Arcosa Inc is a manufacturer and producer of infrastructure-related products and solutions in the U... Show more
Arcosa, Inc. (NYSE: ACA) shares are hovering around $145, just below the $150 per-share cash offer announced by CRH plc (CRH) on June 22, 2026. The stock has effectively been anchored to deal dynamics since the announcement, with daily trading ranges compressing as the spread between market price and deal price narrows. With a 52-week range of $81.91 to $146.92 and a market capitalization of roughly $7.12 billion, the stock's near-term trajectory is largely dictated by merger arbitrage calculus rather than standalone fundamental performance. The company has suspended forward guidance while the transaction is pending, and Arcosa will not host a regular earnings call, shifting investor focus to regulatory milestones and deal-completion probability.
Headquartered in Dallas, Texas, Arcosa is a provider of infrastructure-related products and solutions, formed in 2018 through the spin-off of Trinity Industries' construction products business. The company operates through two principal segments following the April 2026 divestiture of its inland barge and marine components business. The Construction Products segment encompasses natural and recycled aggregates, specialty materials, asphalt, and trench-safety equipment, supported by 109 quarries and yards across strategic U.S. markets including Texas, New Jersey, Arizona, Florida, and Tennessee. The Engineered Structures segment holds a top-three market position in utility transmission structures, wind towers, and related infrastructure, benefiting from secular tailwinds tied to grid modernization, electrification, and data center construction. Arcosa's competitive moat stems from its quarry network proximity to high-growth metropolitan areas, creating natural barriers to entry given the prohibitive cost of long-distance heavy-material transport.
The dominant catalyst for Arcosa in recent weeks has been CRH's agreement to acquire 100% of the company for $150 per share in cash, representing a total enterprise value of approximately $8.5 billion and a 25% premium to Arcosa's 60-day volume-weighted average trading price as of June 18, 2026. CRH, the leading global building materials provider, expects the deal to be accretive to earnings, margins, and cash flow within the first 12 months post-completion, with $175 million in projected run-rate cost synergies by year three. The boards of both companies unanimously approved the transaction.
In response to the deal, several Wall Street firms recalibrated their ratings. Oppenheimer downgraded Arcosa from Outperform to Market Perform on June 26, while Citigroup and Texas Capital both moved to Hold-equivalent ratings on June 23. Previously, Barclays had raised its price target to $140 with an Overweight rating in early May. The average analyst price target now sits at $138.33, well below the $150 deal price but reflecting pre-announcement valuation frameworks.
On the earnings front, Arcosa delivered $0.51 per share in Q1 2026, comfortably exceeding the $0.13 consensus estimate, though revenue of $571.7 million missed expectations of $642.4 million. The company completed the $450 million sale of its barge business on April 1, simplifying its portfolio around Construction Products and Engineered Structures. Arcosa also declared a quarterly dividend of $0.05 per share, payable July 31, 2026, with an ex-dividend date of July 15.
For investors seeking data-driven approaches to navigate events like mergers, earnings seasons, and sector rotations, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron hosts hundreds of automated trading bots that collectively trade thousands of tickers, but only the strongest performers and most strategically relevant bots are featured in this section. Each bot applies distinct strategies, operates across different timeframes, and is evaluated on verifiable performance metrics, allowing traders to explore models that align with their risk tolerance and investment horizon. Whether markets are driven by M&A activity, macroeconomic shifts, or earnings catalysts, these AI tools can help identify patterns and opportunities that manual analysis might overlook.
Looking ahead, the Arcosa investment narrative is fundamentally tied to the CRH acquisition timeline. Key milestones include the Arcosa stockholder vote, regulatory approvals—particularly any antitrust review of combined aggregates market share in overlapping regions—and the satisfaction of customary closing conditions. The transaction is expected to close in Q1 2027. Should any regulatory complications arise or the deal face delays, the stock could experience renewed volatility.
Beyond deal mechanics, Arcosa's Q2 2026 earnings report on August 5 will provide a final look at standalone operating performance. Investors should monitor aggregates volume and pricing trends, utility-structure backlog growth, and progress on capacity-expansion projects including the Illinois wind-tower-plant conversion to power-pole production. Broader infrastructure spending trends, federal highway reauthorization progress, and steel-tariff developments also remain relevant to the underlying business, although their impact on the stock is muted while the acquisition remains pending. The company's strategic decision to exit the barge segment and focus exclusively on construction materials and engineered structures positions both business lines to benefit from multi-year infrastructure investment tailwinds—a rationale CRH explicitly cited in the deal announcement.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACA advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for ACA moved out of overbought territory on July 20, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on August 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACA as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.386) is normal, around the industry mean (17.179). P/E Ratio (32.357) is within average values for comparable stocks, (221.861). Projected Growth (PEG Ratio) (2.237) is also within normal values, averaging (3.120). Dividend Yield (0.001) settles around the average of (0.012) among similar stocks. P/S Ratio (2.441) is also within normal values, averaging (3.242).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of infrastructure related products
Industry EngineeringConstruction